Johnson & Johnson fined $572M in landmark opioid crisis trial


>>Charles: WE JUST LEARNED THAT IN OKLAHOMA AND JUDGE RULED AGAINST JOHNSON & JOHNSON AND THE MULTIBILLION-DOLLAR LAWSUITS FOR SPREADING MISINFORMATION TO DOCTORS IN THE PUBLIC IN THE MARKETING OF POTENTIAL PAINKILLERS. CASEY STENGEL HAS MORE. CASEY? STICKLEY, WE HAVE BEEN WATCHING THIS AS IT’S BEEN BRAGGING THIS AFTERNOON. ANALYSTS SAY THIS HAS REALLY BEEN A LANDMARK CASE BECAUSE IT NOW SETS A LEGAL FOR THOUSANDS OF OTHER PENDING CASES THAT HAVE ALREADY BEEN FILED FROM THE OTHER MUNICIPALITIES. OTHER GOVERNMENTS AGAINST OTHER OPIOID MANUFACTURERS AND DISTRIBUTORS. SO THIS AFTERNOON, THIS PARTICULAR CASE, THE STATE OF OKLAHOMA VERSUS JOHNSON & JOHNSON, IT WAS THE FIRST WANT TO GO TO TRIAL AND JUST MOMENTS AGO, THIS IS WHAT THE JUDGE READ FROM THE BENCH. LISTEN.>>IMMINENT DANGER AND A MENACE TO OKLAHOMANS. MY JUDGMENT INCLUDES FINDINGS FOR THAT AND THE CONCLUSIONS OF LAW THAT THE STATE MET ITS BURDEN THAT THE DEFENDANT JOHNSON & JOHNSON MISLEADING MARKETING AND PROMOTION OF OPIOIDS CREATED A NUISANCE AS DEFINED BY A FINDING THAT THOSE ACTIONS COMPROMISE THE HEALTH AND SAFETY OF THOUSANDS OF OKLAHOMANS.>>SO AGAIN, THAT WAS JUST MOMENTS AGO UP IN NORMAN, OKLAHOMA. THIS IS VERY SUBSTANTIAL RULING BECAUSE AGAIN, THE STATE OF THE JOHNSON & JOHNSON OF USING THESE DECEPTIVE MARKETING PRACTICES AND PUSHING DOCTORS TO PRESCRIBE MORE OPIOIDS WHILE TELLING PATIENTS THAT THE DRUGS WERE SAFE ALL WHILE THE DOWNPLAYING HOW ADDICTIVE THESE PRESCRIPTION PAINKILLERS WERE. LAWYERS FOR JOHNSON & JOHNSON ARGUE THAT THE DRUG COMPANY DID NOT AT ALL BECAUSE THE OPIOID CRISIS SAYING THAT THE COMPANY FOLLOWED THE FDA’S OWN GUIDELINES BACK IN 2009 REGARDING THAT DRUG CLASSIFICATION AND HOW IT IS MARKETED. AGAIN, I RATE A MAJOR RULING UP IN OKLAHOMA TODAY. NO WORRY ON YET JOHNSON & JOHNSON WILL APPEAL

Leave a Reply

Your email address will not be published. Required fields are marked *